201.1 OuTSMARTing donor specific antibodies (DSA): De novo DSA are preceded by a lack of specific regulation of CD4+ Th-1 Cells to DSA antigens but not other donor mismatches
Sumoyee Basu, United Kingdom
201.2 Patients remaining donor specific antibody (DSA) negative post transplantation have more regulated and fewer antigen specific Th-1 cell responses to mismatched donor human leucocyte antigens (HLA) versus those who develop DSA
Dr. Hatty A A Douthwaite, United Kingdom
201.3 Evaluating a Decentralized dd-cfDNA Assay for Kidney Allograft Rejection Monitoring: A Comparative Analysis
Dr. Thierry Viard, United States
201.4 The combination of urine CXCL10 and donor-derived cell free DNA in the non-invasive diagnosis of antibody mediated and T cell mediated rejection in kidney transplantation
Dr. Daniel Fantus, Canada
201.5 Regulation of gamma interferon and interleukin 17a Human Leucocyte Antigen specific T Cell responses differ according to the route of sensitisation
Kate Bramham, United Kingdom
201.7 The impact of mitochondrial stress on the prognosis of recipients with acute T-cell rejection in liver allografts